Who Are We?

About SIP

The "Societal Impact of Pain" (SIP) is an international platform created in 2009 as a joint initiative of the European Pain Federation EFIC® and the pharmaceutical company Grünenthal GmbH.

SIP on Tour

SIP National

The national SIP representatives and endorsers have started to build up national Societal Impact of Pain (SIP) platforms in Europe.

EU Platform

SIP Thematic Network

If you have not yet endorsed the
SIP Joint Statement, there is still time.

NEWSROOM

Latest News

show all
SIP Malta has been the first SIP national platform in Europe which has been established in 2016 on the occasion of the SIP 2017 Symposium held in June 2017during  the Maltese Presidency of the EU council. Due to the lack of data on the needs of pain patients in Malta a research project was initiated with public funding from VOPs. The impressing results of the research project have been presented and discussed with policy makers and other stakeholders in a conference in April 2018.

SIP Malta Workshop January 2020

SIP Malta has been the first SIP national platform in Europe which has been established in 2016 on the occasion of the SIP 2017 Symposium held in June…

Read more …

As a good start in 2020 the European commission published a dedicated issue on pain "‘Why do people develop chronic pain" in the “Horizon, the EU research & Innovation magazine“. The article contains information on two Projects supported by the European Commission: „DoloRisk Understanding risk factors and determinants for neuropathic pain „ and „Cordis: Decomposition of pain into celltypes”.

Why do people develop chronic pain?

As a good start in 2020 the European commission published a dedicated issue on pain "‘Why do people develop chronic pain" in the “Horizon, the EU rese…

Read more …

Finland is the 8th country in Europe to launch the “Societal Impact of Pain” (SIP) platform. The kick-off seminar was held in November 29th, 2019 in Helsinki. SIP is an international platform that provides opportunities for discussion for health care professionals, pain advocacy groups, politicians, healthcare insurance providers, representatives of health authorities, regulators and budget holders in European countries. SIP FIN seminar was organized by Finnish Pain Association, Finnish Musculoskeletal Association TULE and Finnish Association for the Study of Pain.

First seminar to launch SIP Finland

Finland is the 8th country in Europe to launch the “Societal Impact of Pain” (SIP) platform. The kick-off seminar was held in November 29th, 2019 in H…

Read more …

SIP EVENTS

Upcoming Events

show all
Sunday, 19th January 2020
The London Pain Forum

London Pain Forum 8th “Advances in Pain Medicine” International Winter Symposium

The London Pain Forum "Advances in Pain Medicine" International Winter Symposium will return for the EIGHTH time to Hotel Village Montana, Tignes Le L…

Tuesday, 28th January 2020
LAUNCH OF THE INTEREST GROUP ON PATIENTS’ RIGHT AND CROSS-BORDER HEALTHCARE - SECOND TERM (2019-2024): “JOINED FOR VACCINATION: ADDRESSING VACCINE HESITANCY AND INCREASING UPTAKE IN EU. A MULTI-STAKEHOLDER PERSPECTIVE”
The Official launch for the 2019-2024 term, of the MEPs Interest Group “European Patients' Rights & Cross-Border Healthcare” will be held in Brussels inside the European Parliament on January 28th from 16:00 to 18:00 in room ASP 3H1. The event is titled “Joined For Vaccination: addressing Vaccine Hesitancy and Increasing Uptake in EU. A Multi-Stakeholder Perspective”, hosted by the Italian MEP Brando Benifei, co-chair of the Interest Group.
The framework
Vaccination is one of the most important public health tools of the 20th century that led to several crucial goals. Indeed, it has led to eradication of small pox, elimination of poliomyelitis from Europe and dramatic decrease of mortality and morbidity of communicable diseases preventable by vaccination. It is estimated that worldwide vaccination prevents 2.7 million cases of measles, 2 million cases of neonatal tetanus, and 1 million cases of pertussis each year. In Europe, seasonal influenza vaccination prevents around 2 million cases each year.
However, vaccination programs are facing considerable challenges, such as a decline in vaccination coverage in some countries, measles outbreaks and shortages in supply. In addition, misconceptions about vaccination can further shift the public focus from the individual and collective benefits of vaccination to distrust and vaccination hesitancy. A study presented at this year's EU-JAV Annual Meeting shed light on public behavior about vaccination on social media. However, there are not only challenges; there are also many best practices and opportunities, such as a new legislation in the Italian Region of Tuscany, which allows the General Practitioner to administer vaccinations but also new actors such as VAC4EU.
In the autumn of 2019, hundreds of thousands of Europeans will visit their general practitioner to get “the flu shot” in order to protect themselves from one of the most common epidemics; influenza. It is no coincidence that during these months, when public awareness around vaccination is especially high, we take advantage of the momentum by joining our forces in different events around vaccination. In the past autumn weeks, many events, meetings and awareness programs have been launched. These events were held at all levels; these include the Global Summit on Vaccination held by WHO, the 2nd meeting of the Coalition for Vaccination held in Brussels, the European Health Forum Gastein, as well other initiatives at national level. Last but not least, the above mentioned European Joint Action on Vaccination already held its annual meeting in October. In all of these initiatives, ACN has participated with the objective of promoting better citizen engagement in the context of life-course immunization approach.
Goals of the initiative

The conference aims to sensitize the new EU Institutions on the topic and to ensure that the newly elected Members of the European Parliament carry forward the commitment on the topic for this legislature period, as confirmed by the MEPs Interest Group “EU Patients’ Rights & Cross- Border Healthcare” that decided to realize its first initiative addressing vaccination.
To make sure that the initiatives undertaken by the EU Joint Action on Vaccination are better disseminated and to facilitate the EU-JAV effort. This event is an opportunity for EU-JAV to spread information about the work which has been done by EU-JAV to a wider audience, both institutions and other stakeholders including citizens and patients' organizations/advocacy groups, etc.
to contribute to share best practices among all stakeholders involved in the field of citizens engagement on vaccination.

For further information or a registration form, please visit the official website of the event.

Official launch of MEPs interest group “European Patients' Rights & Cross-Border Healthcare”

LAUNCH OF THE INTEREST GROUP ON PATIENTS’ RIGHT AND CROSS-BORDER HEALTHCARE - SECOND TERM (2019-2024): “JOINED FOR VACCINATION: ADDRESSING VACCINE…

Friday, 31st January 2020
111. Aachener Hospizgespräch - 13. Nationaler gesundheitspolitischer Palliativ- und Hospizkongress

111. Aachener Hospizgespräch

111. Aachener Hospizgespräch - 13. Nationaler gesundheitspolitischer Palliativ- und Hospizkongress "Challenges and Opportunities of Cooperation" The …

Media

Are you looking for publications, videos and photos of our work?

In our comprehensive media database you will find everything relating to SIP events and topics.

Media

Reset filters

Permanently well informed

Subscribe to our NEWSLETTER

  1. Societal Impact of Pain (SIP)
  2. Index
  • Register for the SIP Newsletter

    Stay informed about the most important events and news about the Societal Impact of Pain platform.

    subscribe now